Annual Interest Expense
$225.51 M
+$38.33 M+20.47%
December 31, 2024
Summary
- As of March 14, 2025, RPRX annual interest expense is $225.51 million, with the most recent change of +$38.33 million (+20.47%) on December 31, 2024.
- During the last 3 years, RPRX annual interest expense has risen by +$59.37 million (+35.73%).
- RPRX annual interest expense is now -19.45% below its all-time high of $279.96 million, reached on December 31, 2018.
Performance
RPRX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$65.76 M
-$745.00 K-1.12%
December 31, 2024
Summary
- As of March 14, 2025, RPRX quarterly interest expense is $65.76 million, with the most recent change of -$745.00 thousand (-1.12%) on December 31, 2024.
- Over the past year, RPRX quarterly interest expense has increased by +$18.51 million (+39.16%).
- RPRX quarterly interest expense is now -4.93% below its all-time high of $69.17 million, reached on June 30, 2019.
Performance
RPRX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$225.51 M
+$18.51 M+8.94%
December 31, 2024
Summary
- As of March 14, 2025, RPRX TTM interest expense is $225.51 million, with the most recent change of +$18.51 million (+8.94%) on December 31, 2024.
- Over the past year, RPRX TTM interest expense has increased by +$38.33 million (+20.47%).
- RPRX TTM interest expense is now -16.03% below its all-time high of $268.57 million, reached on December 31, 2019.
Performance
RPRX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
RPRX Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.5% | +39.2% | +20.5% |
| 3 y3 years | +35.7% | +39.2% | +20.5% |
| 5 y5 years | -16.0% | +39.2% | +20.5% |
RPRX Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.7% | -1.1% | +48.7% | at high | +35.7% |
| 5 y | 5-year | -16.0% | +43.6% | -1.1% | +109.1% | -16.0% | +60.1% |
| alltime | all time | -19.4% | +43.6% | -4.9% | +109.1% | -16.0% | +235.3% |
Royalty Pharma Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $225.51 M(+20.5%) | $65.76 M(-1.1%) | $225.51 M(+8.9%) |
| Sep 2024 | - | $66.51 M(+35.7%) | $207.01 M(+11.0%) |
| Jun 2024 | - | $49.01 M(+10.8%) | $186.53 M(+1.1%) |
| Mar 2024 | - | $44.23 M(-6.4%) | $184.47 M(-1.5%) |
| Dec 2023 | $187.19 M(-0.4%) | $47.26 M(+2.7%) | $187.19 M(+0.2%) |
| Sep 2023 | - | $46.03 M(-2.0%) | $186.89 M(-0.5%) |
| Jun 2023 | - | $46.95 M(-0.0%) | $187.83 M(-0.0%) |
| Mar 2023 | - | $46.95 M(-0.0%) | $187.85 M(-0.1%) |
| Dec 2022 | $187.96 M(+13.1%) | $46.95 M(-0.0%) | $187.96 M(-0.0%) |
| Sep 2022 | - | $46.98 M(+0.0%) | $187.98 M(+1.4%) |
| Jun 2022 | - | $46.97 M(-0.2%) | $185.33 M(+5.4%) |
| Mar 2022 | - | $47.06 M(+0.2%) | $175.79 M(+5.8%) |
| Dec 2021 | $166.14 M | $46.97 M(+6.0%) | $166.14 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $44.33 M(+18.4%) | $157.01 M(+8.9%) |
| Jun 2021 | - | $37.43 M(+0.0%) | $144.13 M(+2.3%) |
| Mar 2021 | - | $37.41 M(-1.1%) | $140.89 M(-10.3%) |
| Dec 2020 | $157.06 M(-41.5%) | $37.84 M(+20.3%) | $157.06 M(-14.0%) |
| Sep 2020 | - | $31.44 M(-8.0%) | $182.56 M(-17.0%) |
| Jun 2020 | - | $34.19 M(-36.2%) | $219.91 M(-13.7%) |
| Mar 2020 | - | $53.58 M(-15.4%) | $254.89 M(-5.1%) |
| Dec 2019 | $268.57 M(-4.1%) | $63.34 M(-7.9%) | $268.57 M(+30.9%) |
| Sep 2019 | - | $68.80 M(-0.5%) | $205.23 M(+50.4%) |
| Jun 2019 | - | $69.17 M(+2.8%) | $136.43 M(+102.8%) |
| Mar 2019 | - | $67.27 M | $67.27 M |
| Dec 2018 | $279.96 M(+13.2%) | - | - |
| Dec 2017 | $247.34 M | - | - |
FAQ
- What is Royalty Pharma annual interest expense?
- What is the all time high annual interest expense for Royalty Pharma?
- What is Royalty Pharma annual interest expense year-on-year change?
- What is Royalty Pharma quarterly interest expense?
- What is the all time high quarterly interest expense for Royalty Pharma?
- What is Royalty Pharma quarterly interest expense year-on-year change?
- What is Royalty Pharma TTM interest expense?
- What is the all time high TTM interest expense for Royalty Pharma?
- What is Royalty Pharma TTM interest expense year-on-year change?
What is Royalty Pharma annual interest expense?
The current annual interest expense of RPRX is $225.51 M
What is the all time high annual interest expense for Royalty Pharma?
Royalty Pharma all-time high annual interest expense is $279.96 M
What is Royalty Pharma annual interest expense year-on-year change?
Over the past year, RPRX annual interest expense has changed by +$38.33 M (+20.47%)
What is Royalty Pharma quarterly interest expense?
The current quarterly interest expense of RPRX is $65.76 M
What is the all time high quarterly interest expense for Royalty Pharma?
Royalty Pharma all-time high quarterly interest expense is $69.17 M
What is Royalty Pharma quarterly interest expense year-on-year change?
Over the past year, RPRX quarterly interest expense has changed by +$18.51 M (+39.16%)
What is Royalty Pharma TTM interest expense?
The current TTM interest expense of RPRX is $225.51 M
What is the all time high TTM interest expense for Royalty Pharma?
Royalty Pharma all-time high TTM interest expense is $268.57 M
What is Royalty Pharma TTM interest expense year-on-year change?
Over the past year, RPRX TTM interest expense has changed by +$38.33 M (+20.47%)